DIALYSIS · CCN 162549

DaVita Ames Mary Greeley Dialysis

AMES, IA 50010

DialysisProfitDaVita
$4.6M
TOTAL REVENUE
40.6%
OPERATING MARGIN
5 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.6M
Total costs
$2.8M
Operating income (rev − costs)
$1.9M
Operating margin
40.6%
Total charges
$4.7M
Total treatments
9,075
Dialysis stations
16

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.881—
Fistula Rate
DFC_FISTULA_RATE
65.456—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
2.8937—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
12——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
162.480—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.6——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
856—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
24.4295—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
23.662—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
25.661—
Standardized ED Visits Ratio
DFC_SEDR
0.9354—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
46.342—